Literature DB >> 9811201

The reliability of alcoholism history in patients with alcohol-related cirrhosis.

W R Yates1, D R Labrecque, D Pfab.   

Abstract

Alcoholic liver disease is considered an indication for liver transplantation when a candidate is felt to have a high likelihood of abstinence following transplantation. Historical variables such as duration of sobriety, duration and quantity of drinking, and treatment history are commonly used to estimate alcoholism prognosis, yet their reliability and validity in patients with alcoholic cirrhosis has received limited study. Fifty subjects (9 women and 41 men) with alcoholic cirrhosis underwent an alcoholism history interview. Each subject had a collateral source (usually a spouse) who was interviewed by a second interviewer blind to the subject's alcoholism history. The two histories were compared for duration of abstinence in months and estimated alcoholism relapse risk was calculated using the High-risk Alcoholism Relapse scale (HRAR). Duration of sobriety correlated highly between subject and collateral source (Spearman r= 0.96, P = 0.0001) as did HRAR total score (Spearman r = 0.72, P = 0.0001). Categorical assignments also showed high correlations with duration of sobriety (kappa = 0.97) and HRAR category (kappa = 0.63). When disagreements were present, collateral sources tended to underestimate severity of alcoholism. We conclude that patients with alcoholic liver disease provide a reliable history for alcoholism variables when compared with a collateral source, and that, when disagreements are present, subjects tend to report a more acute or severe alcohol problem. The results support the clinical use of patient history information in making decisions about medical interventions for alcoholic liver disease.

Entities:  

Mesh:

Year:  1998        PMID: 9811201     DOI: 10.1093/alcalc/33.5.488

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  8 in total

Review 1.  Long-term survival after liver transplantation for alcoholic liver disease.

Authors:  Paula Iruzubieta; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Liver transplantation for alcoholic liver disease.

Authors:  Vibha Varma; Kerry Webb; Darius F Mirza
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

3.  Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center.

Authors:  Giovanni Addolorato; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Cristina D'Angelo; Gabriele Vassallo; Anthony Cossari; Giovanni Gasbarrini; Raffaele Landolfi; Salvatore Agnes; Antonio Gasbarrini
Journal:  Alcohol Clin Exp Res       Date:  2013-04-11       Impact factor: 3.455

Review 4.  Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.

Authors:  José Ursic-Bedoya; Stéphanie Faure; Hélène Donnadieu-Rigole; Georges-Philippe Pageaux
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

5.  Fetal nicotine exposure increases preference for nicotine odor in early postnatal and adolescent, but not adult, rats.

Authors:  Nicole M Mantella; Paul F Kent; Steven L Youngentob
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

6.  Prenatal alcohol exposure increases postnatal acceptability of nicotine odor and taste in adolescent rats.

Authors:  Nicole M Mantella; Steven L Youngentob
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

7.  Drinking pattern in persons with alcohol dependence with and without cirrhosis: A hospital-based comparative study.

Authors:  Anil Kakunje; Haridas Kanaradi; Ganesh Pai; Ravichandra Karkal; Dilshana Nafisa; Premchand Chandrasekaran
Journal:  Indian J Psychiatry       Date:  2018 Apr-Jun       Impact factor: 1.759

Review 8.  Liver transplantation and alcoholic liver disease: History, controversies, and considerations.

Authors:  Claudio Augusto Marroni; Alfeu Medeiros Fleck; Sabrina Alves Fernandes; Lucas Homercher Galant; Marcos Mucenic; Mario Henrique de Mattos Meine; Guilherme Mariante-Neto; Ajacio Bandeira de Mello Brandão
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.